HumanOptics

DGAP-News: HumanOptics AG: Merger Squeeze-out registered

DGAP-News: HumanOptics AG / Key word(s): Squeeze Out
HumanOptics AG: Merger Squeeze-out registered

12.11.2021 / 14:14
The issuer is solely responsible for the content of this announcement.


HumanOptics AG: Merger Squeeze-out registered

November 12, 2021: HumanOptics Holding AG, Erlangen ("HOH"), and
HumanOptics AG, Erlangen ("HO"), have signed a merger agreement on
May 25, 2021, which provides for the exclusion of the remaining shareholders of HO (minority shareholders) in connection with the merger. On July 6, 2021, the extraordinary general meeting of HO resolved to transfer the shares of the minority shareholders of HO to the majority shareholder HOH against an adequate cash compensation in the amount of EUR 8.71 pursuant to Sections 327a et seqq. of the German Stock Corporation Act (AktG) in conjunction with Section 62 para. 5 of the German Transformation Act (UmwG).

Today, the transfer resolution has been registered with the commercial register of HO at the local court of Fürth under HRB 7714 pursuant to Section 62 para. 5 sentence 7 UmwG with the remark that this resolution shall only become effective simultaneously with the registration of the merger in the commercial register of the acquiring company. The merger was also registered today with the commercial register of HOH at the local court of Fürth under HRB 18844. With the registration of the transfer resolution with the commercial register of HO and the registration of the merger with the commercial register of HOH, all shares held by the minority shareholders of HO were transferred to the ownership (Eigentum) of HOH by law. At the same time, the merger has become effective.

The listing of the shares of HO is expected to end shortly.

For the settlement of the cash compensation, please refer to the notification that HOH will soon publish in the German Federal Gazette (Bundesanzeiger).

HumanOptics Holding AG

Contact:

HumanOptics Holding AG
Investor Relations
Spardorfer Str. 150
91054 Erlangen
Germany
Phone: +49 (0) 9131 50665-0
E-Mail:



12.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: HumanOptics AG
Spardorfer Str. 150
91054 Erlangen
Germany
Phone: +49 (0)9131 - 50665-60
Fax: +49 (0)9131 - 50665-93
E-mail:
Internet:
ISIN: DE000A1MMCR6, DE000A255FK8
WKN: A1MMCR
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Stuttgart
EQS News ID: 1248722

 
End of News DGAP News Service

1248722  12.11.2021 

fncls.ssp?fn=show_t_gif&application_id=1248722&application_name=news&site_id=research_pool
EN
12/11/2021

Reports on HumanOptics

 PRESS RELEASE

DGAP-News: HumanOptics AG: Merger Squeeze-out registered

DGAP-News: HumanOptics AG / Key word(s): Squeeze Out HumanOptics AG: Merger Squeeze-out registered 12.11.2021 / 14:14 The issuer is solely responsible for the content of this announcement. HumanOptics AG: Merger Squeeze-out registered November 12, 2021: HumanOptics Holding AG, Erlangen ("HOH"), and HumanOptics AG, Erlangen ("HO"), have signed a merger agreement on May 25, 2021, which provides for the exclusion of the remaining shareholders of HO (minority shareholders) in connection with the merger. On July 6, 2021, the extraordinary general meeting of HO resolved to tr...

 PRESS RELEASE

DGAP-News: HumanOptics AG: Verschmelzungsrechtlicher Squeeze-out einge...

DGAP-News: HumanOptics AG / Schlagwort(e): Squeeze-Out HumanOptics AG: Verschmelzungsrechtlicher Squeeze-out eingetragen 12.11.2021 / 14:14 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. HumanOptics AG: Verschmelzungsrechtlicher Squeeze-out eingetragen 12. November 2021: Die HumanOptics Holding AG, Erlangen ("HOH"), und die HumanOptics AG, Erlangen ("HO"), haben am 25. Mai 2021 einen Verschmelzungsvertrag geschlossen, der die Angabe enthält, dass im Zusammenhang mit der Verschmelzung ein Ausschluss der übrigen Aktionäre der HO (Minderheitsa...

 PRESS RELEASE

DGAP-News: HumanOptics AG: Zulassung für innovative Trifokal-Linse TR...

DGAP-News: HumanOptics AG / Schlagwort(e): Sonstiges HumanOptics AG: Zulassung für innovative Trifokal-Linse TRIVA(R) 19.02.2020 / 16:39 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. HumanOptics: Zulassung für innovative Trifokal-Linse TRIVA(R) Erlangen, 18. Februar 2020 - Die HumanOptics AG hat die CE-Kennzeichnung und damit die Zulassung am europäischen Markt für ihre neue Trifokal-Linse TRIVA-aA erhalten. Mit dieser innovativen Intraokularlinse (IOL) erweitert der Spezialist für hochwertige Augenchirurgie-Implantate sein Angebot i...

 PRESS RELEASE

DGAP-News: HumanOptics AG: CE-marking for innovative trifocal lens TRI...

DGAP-News: HumanOptics AG / Key word(s): Miscellaneous HumanOptics AG: CE-marking for innovative trifocal lens TRIVA(R) 19.02.2020 / 16:39 The issuer is solely responsible for the content of this announcement. HumanOptics: CE-marking for innovative trifocal lens TRIVA(R) Erlangen, 18 February 2020 - HumanOptics AG has received CE marking and thus approval on the European market for its new trifocal lens TRIVA-aA. With this innovative intraocular lens (IOL), the specialist for high-quality ophthalmic surgery implants is expanding its range in the rapidly growing premium ...

 PRESS RELEASE

DGAP-News: HumanOptics AG: Artificial iris from HumanOptics receives U...

DGAP-News: HumanOptics AG / Key word(s): Miscellaneous HumanOptics AG: Artificial iris from HumanOptics receives US health insurance approval 23.01.2020 / 11:00 The issuer is solely responsible for the content of this announcement. Artificial iris from HumanOptics receives US health insurance approval Important step towards expanding market position Erlangen, 23 January 2020 - HumanOptics AG has received health insurance approval for its artificial iris CUSTOMFLEX(R) ArtificialIris in the USA. The specialist for high-quality eye surgery implants is thus further improvi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch